Withdrawal Reactions Associated With Low-Dose Venlafaxine Treatment in a Patient With Premenstrual Dysphoric Disorder

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: It has recently been demonstrated that venlafaxine, a serotonin-norepinephrine reuptake inhibitor, is effective for the treatment of premenstrual dysphoric disorder (PMDD).1,2 However, withdrawal reactions with venlafaxine have been reported. 3–7 Most of these withdrawal reactions were noted in patients with depressive disorder and associated with daily venlafaxine doses of 150 mg or more

J Clin Psychiatry 2004;65(8):1147-1148 [letter]